gip 1 vs glp 1 The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology GLP-1/GIP Receptor Agonists and Diabetic

This work underscores the impact of the Critical Path Institute (C-Path) and the Predictive Safety Testing Consortium (PSTC), demonstrating how FDA-qualified drug-induced kidney injury biomarkers can improve early detection and enable more sensitive and specific monitoring of kidney injury

We need a study in JAMA to tell us that while long covid is characterized by fatigue and brain fog, I know that already, I already did that two years ago, an observational study

Beyond aesthetics, this muscle loss slows metabolism, reduces functional strength, increases fall risk in older adults, and makes long-term weight maintenance substantially harder

In the head-to-head SURMOUNT trial, funded by drug manufacturer Eli Lilly, people who took tirzepatide lost more weight than those who took semaglutide (Ozempic)

You need to reconstitute the powder by adding bacteriostatic water, and the amount of water you add determines the final concentration

As a member, your provider can help recommend the right support pack based on your lab results, goals, and medication planso you get even more from your program